PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer
Abstract Radioresistance is one of the barriers to developing more effective therapies against the most aggressive, triple-negative, breast cancer (TNBC) subtype. In our previous studies, we showed that inhibition of Polo-like Kinase 4 (PLK4) by a novel drug, CFI-400945 significantly enhances the an...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-02-01
|
| Colecção: | Radiation Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13014-024-02410-z |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|